Status:
COMPLETED
Hyperglycemia in Neurosurgery
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
University of Roma La Sapienza
Burdenko Neurosurgery Institute
Conditions:
Hyperglycemia
Postoperative Infection
Eligibility:
All Genders
18-89 years
Brief Summary
Poor glycemic control is recognized as a risk factor for postoperative infection. For the neurosurgical patient, postoperative infection can lead to devastating complications such as meningitis, encep...
Detailed Description
This is a multisite \[3 locations\] prospective observational study of adult patients (18-89 years old) scheduled for elective intracranial (open or endoscopic) procedures that require general anesthe...
Eligibility Criteria
Inclusion
- Adult patients scheduled for elective intracranial (open surgical or endoscopic) intervention
- General anesthesia
- Hospital stay of at least 1 day post-procedure
Exclusion
- Diagnosis of infection (local or systemic) in preoperative period
- Emergency procedures
Key Trial Info
Start Date :
May 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 13 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05236751
Start Date
May 24 2021
End Date
May 13 2023
Last Update
September 28 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118
2
Sapienza University
Rome, Italy
3
Burdenko Neurosurgery Institute
Moscow, Russia